Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer

American Journal of Pathology

Volumn 179, Issue 5, 2011, Pages 2559-2568

  Van Den Hoogen, Christel ^a   Van Der Horst, Geertje ^a   Cheung, Henry ^a   Buijs, Jeroen T ^a   Pelger, Rob C M ^a   Van Der Pluijm, Gabri ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; HERMES ANTIGEN; INTEGRIN RECEPTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST;

ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CARCINOGENICITY; CELL MIGRATION; CELL SUBPOPULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ISOLATION; STEM CELL;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTEGRIN ALPHAV; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PHENOTYPE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY; UP-REGULATION;

EID: 80055009387     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.07.011     Document Type: Article

References (53)

1. M. Frydenberg, P.D. Stricker, and K.W. Kaye Prostate cancer diagnosis and management Lancet 349 1997 1681 1687
2. G.R. Mundy Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 2002 584 593
3. J.T. Buijs, and G. van der Pluijm Osteotropic cancers: from primary tumor to bone Cancer Lett 273 2009 177 193
4. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 2005 10946 10951
5. N. Guzman-Ramirez, M. Voller, A. Wetterwald, M. Germann, N.A. Cross, C.A. Rentsch, J. Schalken, G.N. Thalmann, and M.G. Cecchini In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue Prostate 69 2009 1683 1693
6. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
7. M.J. Pfeiffer, and J.A. Schalken Stem cell characteristics in prostate cancer cell lines Eur Urol 57 2009 246 254
8. A.T. Collins, F.K. Habib, N.J. Maitland, and D.E. Neal Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)- integrin expression J Cell Sci 114 2001 3865 3872
9. R. Birnie, S.D. Bryce, C. Roome, V. Dussupt, A. Droop, S.H. Lang, P.A. Berry, C.F. Hyde, J.L. Lewis, M.J. Stower, N.J. Maitland, and A.T. Collins Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions Genome Biol 9 2008 R83
10. G.J. Klarmann, E.M. Hurt, L.A. Mathews, X. Zhang, M.A. Duhagon, T. Mistree, S.B. Thomas, and W.L. Farrar Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature Clin Exp Metastasis 26 2009 433 446
11. L. Patrawala, T. Calhoun, R. Schneider-Broussard, H. Li, B. Bhatia, S. Tang, J.G. Reilly, D. Chandra, J. Zhou, K. Claypool, L. Coghlan, and D.G. Tang Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 2006 1696 1708
12. C. van den Hoogen, G. van der Horst, H. Cheung, J.T. Buijs, J.M. Lippitt, N. Guzman-Ramirez, F.C. Hamdy, C.L. Eaton, G.N. Thalmann, M.G. Cecchini, R.C. Pelger, and G. van der Pluijm High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer Cancer Res 70 2010 5163 5173
13. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
14. D. Kong, S. Banerjee, A. Ahmad, Y. Li, Z. Wang, S. Sethi, and F.H. Sarkar Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells PLoS One 5 2010 e12445
15. E.M. Hurt, and W.L. Farrar Cancer stem cells: the seeds of metastasis? Mol Interv 8 2008 140 142
16. H.M. Meng, P. Zheng, X.Y. Wang, C. Liu, H.M. Sui, S.J. Wu, J. Zhou, Y.Q. Ding, and J.M. Li Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer Cancer Biol Ther 9 2010 295 302
17. M.A. Kim, H.S. Lee, H.E. Lee, J.H. Kim, H.K. Yang, and W.H. Kim Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma Histopathology 54 2009 442 451
18. M.M. Mueller, and N.E. Fusenig Friends or foes - bipolar effects of the tumour stroma in cancer Nat Rev Cancer 4 2004 839 849
19. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, and R.A. Weinberg Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 2007 557 563
20. A. Albini, and M.B. Sporn The tumour microenvironment as a target for chemoprevention Nat Rev Cancer 7 2007 139 147
21. I.J. Fidler, and G. Poste The "seed and soil" hypothesis revisited Lancet Oncol 9 2008 808
22. E.M. Hurt, K. Chan, M.A. Serrat, S.B. Thomas, T.D. Veenstra, and W.L. Farrar Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation Stem Cells 28 2010 390 398
23. R.O. Hynes The extracellular matrix: not just pretty fibrils Science 326 2009 1216 1219
24. J. Pontes-Junior, S.T. Reis, M. Dall'oglio, L.C. Neves de Oliveira, J. Cury, P.A. Carvalho, L.A. Ribeiro-Filho, K.R. Moreira Leite, and M. Srougi Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer J Carcinog 8 2009 3
25. C. Margadant, and A. Sonnenberg Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing EMBO Rep 11 2010 97 105
26. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J Clin Invest 119 2009 1420 1428
27. G. van der Pluijm Epithelial plasticity, cancer stem cells and bone metastasis formation Bone 48 2011 37 43
28. T. Brabletz, A. Jung, S. Spaderna, F. Hlubek, and T. Kirchner Opinion: migrating cancer stem cellsan integrated concept of malignant tumour progression Nat Rev Cancer 5 2005 744 749
29. K. Kelly, and J.J. Yin Prostate cancer and metastasis initiating stem cells Cell Res 18 2008 528 537
30. A.P. Morel, M. Lievre, C. Thomas, G. Hinkal, S. Ansieau, and A. Puisieux Generation of breast cancer stem cells through epithelial-mesenchymal transition PLoS One 3 2008 e2888
31. J.A. Nemeth, M.T. Nakada, M. Trikha, Z. Lang, M.S. Gordon, G.C. Jayson, R. Corringham, U. Prabhakar, H.M. Davis, and R.A. Beckman Alpha-v integrins as therapeutic targets in oncology Cancer Invest 25 2007 632 646
32. N.P. McCabe, S. De, A. Vasanji, J. Brainard, and T.V. Byzova Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling Oncogene 26 2007 6238 6243
33. J.T. Buijs, C.A. Rentsch, G. van der Horst, P.G. van Overveld, A. Wetterwald, R. Schwaninger, N.V. Henriquez, P. Ten Dijke, F. Borovecki, R. Markwalder, G.N. Thalmann, S.E. Papapoulos, R.C. Pelger, S. Vukicevic, M.G. Cecchini, C.W. Lowik, and G. van der Pluijm BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo Am J Pathol 171 2007 1047 1057
34. J.T. Buijs, N.V. Henriquez, P.G. van Overveld, G. van der Horst, I. Que, R. Schwaninger, C. Rentsch, D.P. Ten, A.M. Cleton-Jansen, K. Driouch, R. Lidereau, R. Bachelier, S. Vukicevic, P. Clezardin, S.E. Papapoulos, M.G. Cecchini, C.W. Lowik, and G. van der Pluijm Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer Cancer Res 67 2007 8742 8751
35. T. Li, Y. Su, Y. Mei, Q. Leng, B. Leng, Z. Liu, S.A. Stass, and F. Jiang ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome Lab Invest 90 2010 234 244
36. C.L. Eaton, M. Colombel, G. van der Pluijm, M. Cecchini, A. Wetterwald, J. Lippitt, I. Rehman, F. Hamdy, and G. Thalman Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer Prostate 70 2010 875 882
37. H. Tanaka, E. Kono, C.P. Tran, H. Miyazaki, J. Yamashiro, T. Shimomura, L. Fazli, R. Wada, J. Huang, R.L. Vessella, J. An, S. Horvath, M. Gleave, M.B. Rettig, Z.A. Wainberg, and R.E. Reiter Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance Nat Med 16 2010 1414 1420
38. K. Tomita, B.A. van, G.J. van Leenders, E.T. Ruijter, C.F. Jansen, M.J. Bussemakers, and J.A. Schalken Cadherin switching in human prostate cancer progression Cancer Res 60 2000 3650 3654
39. S.A. Khan, A.C. Cook, M. Kappil, U. Gunthert, A.F. Chambers, A.B. Tuck, and D.T. Denhardt Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation Clin Exp Metastasis 22 2005 663 673
40. C.R. Cooper, C.H. Chay, and K.J. Pienta The role of alpha(v)beta(3) in prostate cancer progression Neoplasia 4 2002 191 194
41. J.L. Lee, M.J. Wang, P.R. Sudhir, G.D. Chen, C.W. Chi, and J.Y. Chen Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: oPN-CD44V interaction enhances survival in gastrointestinal cancer cells Cancer Res 67 2007 2089 2097
42. G. van der Pluijm, H. Vloedgraven, S. Papapoulos, C. Lowick, W. Grzesik, J. Kerr, and P.G. Robey Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components Lab Invest 77 1997 665 675
43. M. Emadi Baygi, Z.S. Soheili, I. Schmitz, S. Sameie, and W.A. Schulz Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines Cell Biol Toxicol 26 2010 553 567
44. M.H. Yang, D.S. Hsu, H.W. Wang, H.J. Wang, H.Y. Lan, W.H. Yang, C.H. Huang, S.Y. Kao, C.H. Tzeng, S.K. Tai, S.Y. Chang, O.K. Lee, and K.J. Wu Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition Nat Cell Biol 12 2010 982 992
45. N.R. Alexander, N.L. Tran, H. Rekapally, C.E. Summers, C. Glackin, and R.L. Heimark N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1 Cancer Res 66 2006 3365 3369
46. S. Kasper Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens Urol Oncol 27 2009 301 303
47. M. Santisteban, J.M. Reiman, M.K. Asiedu, M.D. Behrens, A. Nassar, K.R. Kalli, P. Haluska, J.N. Ingle, L.C. Hartmann, M.H. Manjili, D.C. Radisky, S. Ferrone, and K.L. Knutson Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells Cancer Res 69 2009 2887 2895
48. G. van der Horst, C. van den Hoogen, J.T. Buijs, H. Cheung, H. Bloys, R.C. Pelger, G. Lorenzon, B. Heckmann, J. Feyen, P. Pujuguet, R. Blanque, P. Clement-Lacroix, and G. van der Pluijm Targeting of alpha(v)-Integrins in Stem/Progenitor Cells and Supportive Microenvironment Impairs Bone Metastasis in Human Prostate Cancer Neoplasia 13 2011 516 525
49. J.J. Worthington, J.E. Klementowicz, and M.A. Travis TGFbeta: a sleeping giant awoken by integrins Trends Biochem Sci 36 2011 47 54
50. B. Desai, M.J. Rogers, and M.A. Chellaiah Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells Mol Cancer 6 2007 18
51. G. van der Pluijm, B. Sijmons, H. Vloedgraven, M. Deckers, S. Papapoulos, and C. Lowik Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases J Bone Miner Res 16 2001 1077 1091
52. T. Yoneda, and T. Hiraga Crosstalk between cancer cells and bone microenvironment in bone metastasis Biochem Biophys Res Commun 328 2005 679 687
53. J.J. Yin, K. Selander, J.M. Chirgwin, M. Dallas, B.G. Grubbs, R. Wieser, J. Massague, G.R. Mundy, and T.A. Guise TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development J Clin Invest 103 1999 197 206